Package 50242-917-01

{"route": ["INTRAVENOUS"], "spl_id": "090baf8e-6c5c-4021-a54c-7373d4df1759", "openfda": {"nui": ["N0000191260", "N0000191259", "M0556300", "M0001357", "M0001352"], "unii": ["52CMI0WC3Y"], "rxcui": ["1792780", "1792785", "2119695", "2119696"], "spl_set_id": ["6fa682c9-a312-4932-9831-f286908660ee"], "pharm_class_cs": ["Antibodies, Monoclonal, Humanized [CS]", "Antibodies, Monoclonal [CS]", "Antibodies [CS]"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-917-01", "marketing_start_date": "20160518"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-917-86", "marketing_start_date": "20160811"}], "brand_name": "TECENTRIQ", "product_id": "50242-917_090baf8e-6c5c-4021-a54c-7373d4df1759", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies [CS]", "Antibodies", "Monoclonal [CS]", "Antibodies", "Monoclonal", "Humanized [CS]", "Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "50242-917", "generic_name": "atezolizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TECENTRIQ", "active_ingredients": [{"name": "ATEZOLIZUMAB", "strength": "1200 mg/20mL"}], "application_number": "BLA761034", "marketing_category": "BLA", "marketing_start_date": "20160518", "listing_expiration_date": "20261231"}